20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells

Oncogene

Volumn 14, Issue 5, 1997, Pages 551-560

  Savelieva, Elena ^a,c   Belair, Cassandra D ^b,c   Newton, Michael A ^a   DeVries, Sandy ^d   Gray, Joe W ^d   Waldman, Frederic ^d   Reznikoff, Catherine A ^a,b,c,e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Environmental Toxicology Center   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e University of Wisconsin Health   (United States)

Author keywords

20q amplification; Genome instability; HPV16 E7; Human uroepithelial cells; Immortalization

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CANCER; CHROMOSOME 10P; CHROMOSOME 20Q; CHROMOSOME LOSS; CONTROLLED STUDY; DOUBLE MINUTE CHROMOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MUTATION RATE; PRIORITY JOURNAL; UROTHELIUM; VIRUS CELL TRANSFORMATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0031054750     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200868     Document Type: Article

References (36)

1. Belair CD, Blelloch RH and Reznikoff CA. (1996). Rad. Oncol. Invest., 3, 368-376.
2. Brinkmann U, Gallo M, Polymeropoulos MH and Pastan I. (1996). Genome Res., 6, 187-194.
3. Davies R, Hicks R, Crook T, Morris J and Vousden K. (1993). J. Virol., 67, 2521-2528.
4. DeCaprio JA, Ludlow JW, Figge J, Shew J-Y, Huang C-M, Lee W-H, Marsillo NG, Paucha E and Livingstone DM. (1988). Cell, 54, 275-283.
5. Dyson N, Howley PM, Munger K and Harlow E. (1989). Science, 243, 934-937.
6. Eyfjörd J, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir HM and Anamthawat-Jonsson K. (1995). Cancer Res., 55, 646-651.
7. Gray JW and Pinkel D. (1991). Cancer Supplement, 69, 1536-1542.
8. Hahn P. (1993). Bioassays, 15, 477-488.
9. Holt, SE, Wright WE and Shay JW. (1996). Mol. Cell. Bio., 16 ,2932-2939.
10. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiu ML, Pinkel D, Yang-Feng TL and Gray JW. (1995). Cancer Res., 55, 6172-6180.
11. Kallioniemi, A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D. (1992). Science, 258, 818-821.
12. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D. (1994a). Genes, Chromo. & Cancer, 10, 231-243.
13. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW and Waldman FM. (1994b). Proc. Natl. Acad. Sci. USA, 91, 2156-2160.
14. Kallioniemi A, Kallioniemi O-P, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P and Waldman F. (1995). Genes, Chromo. & Cancer, 12, 213-219.
15. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH. (1994). Science, 264, 436-440.
16. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. (1992). Cell, 70, 923-935.
17. Mohapatra G, Kim DH adn Feuerstein BG. (1995). Genes, Chromo. & Cancer, 13, 86-93.
18. Muleris M, Almeida A, Gerbault-Seurea M, Malfoy B and Dutrillaux B. (1994). Genes, Chromo. & Cancer, 10, 160-170.
19. Reznikoff CA, Loretz LJ, Pesciotta DM, Oberley TD and Ignjatovic M. (1987). J. Cell. Physiol., 131, 285-301.
20. Reznikoff CA, Belair C, Savelieva E, Zhai Y, Pfeifer K, T. Yeager T, Thompson KJ, DeVries S, Bindley C, Newton MA, Sekhon G and Waldman F. (1994). Genes & Dev., 8, 2227-2240.
21. Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Blelloch RH, Puthenveettil JA and Cuhill S. (1996a). Sem. Oncol. 23, 571-584.
22. Reznikoff CA, Yeager T, Belair CD, Savelieva E, Puthenveettil JA and Stadler WM. (1996b). Cancer Res. 56, 2886-2890.
23. Sandberg AA and Berger CS. (1994). J. Urol., 151, 545-556.
24. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
25. Scherf U, Pastan I, Willingham MC and Brinkmann U. (1996). Proc. Natl. Acad. Sci. USA, 93, 2670-2674.
26. Schimke RT. (1984). Cell, 37, 705-713.
27. Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngible H, Rüschoff and Hofstädter F. (1995). Cancer Res., 55, 6002-6005.
28. Sherr CJ, and Roberts JM. (1995). Genes & Devel., 9, 1149-1163.
29. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo W-L, Waldman FM, Isola JJ, Gray JW and Kallioniemi O-P. (1994). Cancer Res., 54, 4257-4260.
30. Tanner MM, Tirkkonen M, Kallioniemi A, Holli K, Collins C, Kowbel D, Gray JW, Kallioniemi O-P and Isola J. (1995). Clin. Cancer Res., 1, 1455-1461.
31. Tommasino M, Adamczewski JP, Carlotti F, Barth CF, Manetti R, Contorni M, Cavalieri F, Hunt T and Crawford L. (1993). Oncogene, 8, 195-202.
32. White AE, Livanos EM and Tlsty TD. (1994). Genes & Dev., 8, 666-677.
33. Whyte P, Buchovich KL, Horowitz JM, Friend SH, Rayback M, Weinberg R and Harlow E. (1988). Nature, 334, 124-129.
34. Xiao Z, McGrew JT, Schroeder AJ and Fitzgerald-Hayes M. (1993). Mol. Cell. Bio., 13, 4691-4702.
35. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O and Reznikoff C. (1995). Cancer Res., 55, 493-497.
36. Yunis JJ. (1982). Gene Amplification. Schmike RT (ed), Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, pp. 297-302.